Health
Sortilin may hold the key to developing more effective treatment for pancreatic cancer – News-Medical.Net
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States.
Reviewed by Emily Henderson, B.Sc.Aug 20 2020
Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
There is currently no good therapy for pancreatic cancer. What we …
-
General16 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Noosa News22 hours agoFuel tanker driver killed in horror head-on crash near Blackbutt identified as beloved father-of-two
-
Noosa News20 hours agoPalestine protesters forced into last-minute reroute
-
Noosa News20 hours agoSuspected arsonist escapes in car while on fire after botched tobacconist attack